T raditionally, those in the fields of medicine and pharmacy have sought bioethical guidance from moral theologians from various religions on such difficult issues as abortion, euthanasia, and stem cell research. Hospital Pharmacy has published editorials 1,2 on the importance of immunization advocacy to ensure that patient immunization needs are understood and met. It has been noted that some are voicing concern over the sources of biological products. For example, several vaccines that in the past were made from egg or other tissue cultures are now grown in cultures originally derived from embryonic human media. It is important for us to realize that, depending on individual circumstances, patients and staff may have concerns about this method of vaccine production.
In a statement written December 8 and issued December 12, 2008, the Vatican provided an instruction entitled Dignitas Personae 3 (meaning "dignity of the person") that defined and clarified a number of bioethical issues. This text expands teaching from several previously published documents. In a time when it seems the forces of organized naturalism have taken over many facets of society, this writing provides welcome assistance to researchers who use embryonic material and to patients faced with difficult choices concerning vaccination. Although this is a wide-ranging document, I would like to provide a quote from the text that pertains to the use of vaccines derived from human media:
For scientific research and for the production of vaccines or other products, cell lines are at times used which are the result of an illicit intervention against the life or physical integrity of a human being.
Experimentation on human embryos "constitutes a crime against their dignity as human beings who have a right to the same respect owed to a child once born, just as to every person. These forms of experimentation always constitute a grave moral disorder." "Of course, within this general picture there exist differing degrees of responsibility. Grave reasons may be morally proportionate to justify the use of such 'biological material.' Thus, for example, danger to the health of children could permit parents to use a vaccine which was developed using cell lines of illicit origin, while keeping in mind that everyone has the duty to make known their disagreement and to ask that their healthcare system make other types of vaccines available. Moreover, in organiza-tions where cell lines of illicit origin are being utilized, the responsibility of those who make the decision to use them is not the same as that of those who have no voice in such a decision."
The difficulty lies in the fact that some parents may choose not to have vaccines administered to their children, which puts both the children and, potentially, the population as a whole at increased risk for disease transmission. These guidelines may serve as an ethical aid to concerned patients considering the option of vaccination and for staff in understanding the issues some patients may be facing. Prior editorials concluded that it is incumbent on us to do what is possible to make available alternative vaccines, to encourage the pharmaceutical industry to do so as well, and to petition the US Food and Drug Administration to process any such application expeditiously.
